-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MPcziX0eK7uwV0q25vcv1byspn813aSzTwy8NfTzoH1MB+7qNxQCugkA0TvuLr/I m4M0zVe/kvgYEGotgOQToQ== 0000732485-03-000026.txt : 20030708 0000732485-03-000026.hdr.sgml : 20030708 20030708105924 ACCESSION NUMBER: 0000732485-03-000026 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030707 FILED AS OF DATE: 20030708 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENZYME CORP CENTRAL INDEX KEY: 0000732485 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 061047163 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQ CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6172527500 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MOSCICKI RICHARD A CENTRAL INDEX KEY: 0001021029 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14680 FILM NUMBER: 03777956 BUSINESS ADDRESS: STREET 1: C/O GENZYME CORP STREET 2: ONE KENDALL SQ CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6172527500 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 mos57.xml X0101 4 2003-07-07 0 0000732485 GENZYME CORP GENZ 0001021029 MOSCICKI RICHARD A 0 1 0 0 Senior Vice President Genzyme General common stock (GENZ) 2003-07-07 2003-07-07 4 M 0 20000 7.27 A 25831 D Genzyme General common stock (GENZ) 2003-07-07 2003-07-07 4 S 0 100 44.03 D 25731 D Genzyme General common stock (GENZ) 2003-07-07 2003-07-07 4 S 0 1000 44.01 D 24731 D Genzyme General common stock (GENZ) 2003-07-07 2003-07-07 4 S 0 100 44.23 D 24631 D Genzyme General common stock (GENZ) 2003-07-07 2003-07-07 4 S 0 500 44.28 D 24131 D Genzyme General common stock (GENZ) 2003-07-07 2003-07-07 4 S 0 200 44.29 D 23931 D Genzyme General common stock (GENZ) 2003-07-07 2003-07-07 4 S 0 100 44.36 D 23831 D Genzyme General common stock (GENZ) 2003-07-07 2003-07-07 4 S 0 1000 44.30 D 22831 D Genzyme General common stock (GENZ) 2003-07-07 2003-07-07 4 S 0 2900 44.34 D 19931 D Genzyme General common stock (GENZ) 2003-07-07 2003-07-07 4 S 0 2732 44.35 D 17199 D Genzyme General common stock (GENZ) 2003-07-07 2003-07-07 4 S 0 9968 44.37 D 7231 D Genzyme General common stock (GENZ) 2003-07-07 2003-07-07 4 S 0 1300 44.38 D 5931 D Genzyme General common stock (GENZ) 2003-07-07 2003-07-07 4 S 0 100 44.39 D 5831 D Genzyme General NQ stock option (right to buy) 7.27 2003-07-07 2003-07-07 4 M 0 20000 0 D 2003-06-30 2003-12-08 Genzyme General common stock (GENZ) 20000 80000 D The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 28, 2003. The exercise of this stock option included a distribution of an additional 4 shares of Genzyme common stock. These stock options were entitled to receive a distribution of shares of Tissue Repair common stock that was paid on July 22, 1997 to Genzyme General Division stockholders at a rate of 0.015. In connection with the formation of Genzyme Biosurgery in December 2000, shares of Genzyme Tissue Repair were converted into shares of Genzyme Biosurgery at a rate of 0.3352. In connection with the exchange of Genzyme Biosurgery stock into Genzyme General stock on June 30, 2003, distributions of the Genzyme Biosurgery stock are exchanged into Genzyme General stock at a rate of 0.04945. By: Susan P. Cogswell, Attorney-in-Fact 2003-07-08 -----END PRIVACY-ENHANCED MESSAGE-----